GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » Cyclically Adjusted PS Ratio

Coloplast A/S (LTS:0QBO) Cyclically Adjusted PS Ratio : 8.90 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PS Ratio?

As of today (2024-05-21), Coloplast A/S's current share price is kr848.60. Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr95.33. Coloplast A/S's Cyclically Adjusted PS Ratio for today is 8.90.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0QBO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.55   Med: 11.03   Max: 16.78
Current: 8.88

During the past years, Coloplast A/S's highest Cyclically Adjusted PS Ratio was 16.78. The lowest was 7.55. And the median was 11.03.

LTS:0QBO's Cyclically Adjusted PS Ratio is ranked worse than
83.93% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs LTS:0QBO: 8.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Coloplast A/S's adjusted revenue per share data for the three months ended in Mar. 2024 was kr29.310. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr95.33 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PS Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.75 14.58 13.55 8.96 8.09

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 9.43 8.09 8.28 9.74

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PS Ratio falls into.



Coloplast A/S Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Coloplast A/S's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=848.60/95.33
=8.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=29.31/118.4000*118.4000
=29.310

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 14.676 99.700 17.429
201409 15.225 99.700 18.081
201412 15.490 99.400 18.451
201503 16.156 100.200 19.091
201506 16.577 100.300 19.568
201509 17.111 100.200 20.219
201512 17.150 99.800 20.346
201603 16.939 100.200 20.016
201606 17.337 100.600 20.405
201609 17.659 100.200 20.867
201612 17.703 100.300 20.898
201703 18.259 101.200 21.362
201706 18.427 101.200 21.559
201709 18.667 101.800 21.711
201712 18.597 101.300 21.736
201803 19.015 101.700 22.137
201806 19.920 102.300 23.055
201809 19.938 102.400 23.053
201812 20.319 102.100 23.563
201903 20.604 102.900 23.708
201906 21.617 102.900 24.873
201909 21.641 102.900 24.901
201912 22.093 102.900 25.421
202003 22.686 103.300 26.002
202006 20.699 103.200 23.748
202009 21.545 103.500 24.647
202012 22.276 103.400 25.508
202103 22.293 104.300 25.307
202106 22.671 105.000 25.564
202109 23.923 105.800 26.772
202112 24.239 106.600 26.922
202203 25.826 109.900 27.823
202206 27.498 113.600 28.660
202209 28.549 116.400 29.040
202212 28.743 115.900 29.363
202303 28.536 117.300 28.804
202306 28.715 116.400 29.208
202309 27.708 117.400 27.944
202312 30.233 116.700 30.673
202403 29.310 118.400 29.310

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (LTS:0QBO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Coloplast A/S Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (LTS:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines